Product Information

BUSPIRONE HCL 7.5 MG TABLET is a generic product labeled by Advagen Pharma Ltd., priced at $0.1016 per EA under NDC 72888006305. Its NADAC has been published 169 times since Aug 30, 2023.

FDA first approved this application on Apr 5, 2002. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

BUSPIRONE HCL 7.5 MG TABLET

buspirone hydrochloride
$0.1016per EA

Strength

7.5 mg/1

NDC

72888006305

Classification

Generic

Dosage Form

TABLET

Route

ORAL

Effective Date

11/18/2026

Active Ingredients

BUSPIRONE HYDROCHLORIDE

Approval Type

Generic (ANDA)

FDA Application

ANDA075521

FDA Approved

4/5/2002

TE Code

AB

On Market Since

3/16/2021

Price Statistics

The NADAC for BUSPIRONE HCL 7.5 MG TABLET has been published 169 times since Aug 30, 2023, and over the history we have for it it has declined 37.4%. The table below summarizes its recorded NADAC range and movement.

Current price$0.1016 per EA
All-time high$0.1623 (Sep 13, 2023)
All-time low$0.0797 (Nov 20, 2024)
52-week high$0.1212
52-week low$0.0998
Median price$0.1179
Average price$0.1186
Largest weekly change-42.2% (Nov 20, 2024)
Weeks tracked169
Tracking sinceAug 30, 2023

Price History

1W

+1.8%

1M

+1.8%

3M

-2.9%

6M

-8.4%

1Y

-14.7%

3Y

-21.8%

5Y

N/A

All

-37.4%

Generic Alternatives

The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Related Drugs

Same classification

No related drugs found.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of BUSPIRONE HCL 7.5 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for BUSPIRONE HCL 7.5 MG TABLET, manufactured by Advagen Pharma Ltd., is $0.1016 per EA (NDC 72888006305), effective Nov 18, 2026.

How has the price of BUSPIRONE HCL 7.5 MG TABLET changed over time?

Over the history we have for it, the NADAC for BUSPIRONE HCL 7.5 MG TABLET has declined 37.4%. It has been tracked across 169 weekly CMS publications since Aug 30, 2023.

What are the highest and lowest recorded NADAC prices for BUSPIRONE HCL 7.5 MG TABLET?

Since Aug 30, 2023, the NADAC for BUSPIRONE HCL 7.5 MG TABLET has ranged from a low of $0.0797 (Nov 20, 2024) to a high of $0.1623 (Sep 13, 2023), with a median of $0.1179 per EA.

Are there cheaper alternatives to BUSPIRONE HCL 7.5 MG TABLET?

2 manufacturers publish a NADAC-priced product with the same active ingredient and strength as BUSPIRONE HCL 7.5 MG TABLET in a comparable dosage form, but none are currently priced below it.

Who manufactures BUSPIRONE HCL 7.5 MG TABLET?

BUSPIRONE HCL 7.5 MG TABLET (NDC 72888006305) is labeled by Advagen Pharma Ltd., and CMS classifies it as a generic product.